What changed › 2026-10-13
A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbi
Detected 2026-10-13 in the trials record for ecnoglutide, by comparing that day’s fetch against the previous one.
A trial's status changing is often the first public signal that something has gone right or wrong, and it is recorded without announcement.
What changed
| Change | Field | Value |
|---|---|---|
| status changed | status | ACTIVE_NOT_RECRUITING → TERMINATED |
What the record says now
- Status
- Terminated
- Phase
- P2
- Participants
- 8
- Primary completion
- 2026-09-11
- Sponsor
- Verdiva Bio Dev Limited
See ecnoglutide · NCT07553299 · the source record.
The previous value above is not recoverable from the source. Both ClinicalTrials.gov and the FDA revise records in place, keeping no public history, which is why this site keeps its own.